scholarly article | Q13442814 |
P356 | DOI | 10.1002/OBY.21164 |
P698 | PubMed publication ID | 26179846 |
P50 | author | Nimesh Mody | Q57321366 |
Mirela Delibegovic | Q84021168 | ||
P2093 | author name string | Claire Henderson | |
George D Mcilroy | |||
Peter J McCaffery | |||
Kirsty D Shearer | |||
Nicola Morrice | |||
Jenny Reekie | |||
P2860 | cites work | Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance | Q36560629 |
Fenretinide treatment prevents diet-induced obesity in association with major alterations in retinoid homeostatic gene expression in adipose, liver, and hypothalamus. | Q36635330 | ||
Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer. | Q37008398 | ||
Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice | Q37264601 | ||
Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis | Q37474455 | ||
Minireview: Putting physiology back into estrogens' mechanism of action | Q37939510 | ||
Maternal adiposity--a determinant of perinatal and offspring outcomes? | Q38046084 | ||
Impact of parity on obesity: a cross-sectional study in Iranian women | Q40235385 | ||
Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. | Q40496635 | ||
Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide | Q41049278 | ||
Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance. | Q42103747 | ||
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial | Q44269768 | ||
4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors | Q46690362 | ||
Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer | Q24295934 | ||
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes | Q24309211 | ||
Modification of the oestrous cycle of the mouse by external stimuli associated with the male | Q28213059 | ||
Maternal obesity and risk of gestational diabetes mellitus | Q28297113 | ||
Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice | Q28590055 | ||
Serum immunoreactive-leptin concentrations in normal-weight and obese humans | Q29617230 | ||
Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma | Q33347137 | ||
Childbearing is associated with higher incidence of the metabolic syndrome among women of reproductive age controlling for measurements before pregnancy: the CARDIA study | Q33595899 | ||
Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice | Q33655519 | ||
Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. | Q33926507 | ||
Estrogen receptor-{beta}-selective ligands alleviate high-fat diet- and ovariectomy-induced obesity in mice | Q34181302 | ||
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects | Q34538317 | ||
The emergence of the metabolic syndrome with menopause | Q35146342 | ||
Multiparity leads to obesity and inflammation in mothers and obesity in male offspring | Q35780719 | ||
Increased adipose tissue in male and female estrogen receptor-alpha knockout mice | Q35823619 | ||
Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity | Q35823766 | ||
Recent female mouse models displaying advanced reproductive aging | Q36341058 | ||
Clinical trials with retinoids for breast cancer chemoprevention | Q36443030 | ||
P433 | issue | 8 | |
P921 | main subject | obesity | Q12174 |
P304 | page(s) | 1655-1662 | |
P577 | publication date | 2015-07-14 | |
P1433 | published in | Obesity | Q15763232 |
P1476 | title | Fenretinide prevents obesity in aged female mice in association with increased retinoid and estrogen signaling | |
P478 | volume | 23 |
Q39399025 | Alterations in vitamin A/retinoic acid homeostasis in diet-induced obesity and insulin resistance. |
Q47246053 | Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD). |
Q37678960 | Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice. |
Q39076546 | Gene expression modulation of lipid and central energetic metabolism related genes by high-fat diet intake in the main homeostatic tissues |
Q47555468 | Modest Decreases in Endogenous All-Trans-Retinoic Acid Produced by a Mouse Rdh10 Heterozygote Provoke Major Abnormalities in Adipogenesis and Lipid Metabolism. |